US Forensic Genomics Market 2025 – 2034

As per the US Forensic Genomics Market analysis conducted by the CMI team, the US forensic genomics market is expected to record a CAGR of 16.35% from 2025 to 2034. In 2025, the market size was USD306.78 Million. By 2034, the valuation is anticipated to reach USD 1192.35 Million.

Overview

The US forensic genomics market does demonstrate a high level of innovation, which is driven by quick advancements in NGS, data analytics, and bioinformatics. Such innovations have noticeably improved the precision, sensitivity, and speed pertaining to DNA analysis, thereby facilitating resolution of complex cases that involve mixed or degraded samples.

Emerging capacities such as ancestry inference, phenotypic prediction, and familial searching are driving the scope of forensic applications well beyond conventional identification methods. For example, Florida, in July 2025, did implement one of the advanced DNA testing methods for resolving cold cases in a more efficient manner. This kind of approach does make use of forensic genetic genealogy, thereby combining genealogical research with DNA analysis for identifying suspects in the unsolved crimes. Continual investments in research & development activities of real-time and portable genomic tools further drive the evolving nature of innovation.

Key Trends & Drivers

• Rise in Crime Cases in the US

Forensic evidence is turning out to be increasingly vital in various criminal cases as it could be used for proving/disproving links amongst victims, suspects, and crime scenes. Forensic evidence analysis does involve the study of crime scene, DNA testing, forensic DNA, bloodstain patterns, and DNA profiling. As per the data published by the US Centers for Disease Control and Prevention (CDC), the number of homicides in the US alone was over 24,000 as of the year 2024.

• Advancements in DNA Sequencing Technology

Rise in adoption of advanced DNA sequencing technologies such as NGS and massively parallel sequencing (MPS) is basically expediting the US forensic genomics market. Such technologies do allow more precise, quicker, and cost-effective analysis of DNA samples, which is imperative for forensic applications.

MPS and NGS technologies are enabling forensic scientists to identify as well as analyze the genetic markers more efficiently, thereby resulting in improved reliability and accuracy in DNA identification and profiling. Plus, the development of handheld and portable DNA sequencing devices has made it possible to perform forensic analysis in this field, thereby cutting down on cost and time related to conventional laboratory-based methods.

What’s trending in the US Forensic Genomics Market?

Chemical electrophoresis dominates the US forensic genomics market due to a rise in investments by private and public organizations in this regard. On these grounds, QIAGEN, in January 2023, announced that it had completed the acquisition of Verogen with the objective of driving the future of forensic investigation and human identification (HID). Polymerase chain reaction is also witnessing a visible demand due to the rise in the number of criminal cases.

Key Threats

• Data Usage and Genetic Privacy

Using forensic genetic genealogy (FGG) with commercial DNA databases does raise sizable privacy and ethical concerns. There are debates around informed consent, genetic privacy, and proper usage of such databases, which are creating regulatory and legal challenges, thereby necessitating development of the novel governance policies.

Also, the US regulatory environment that encompasses the approval process for the new genetic technologies and tests by the US FDA could be lengthy and complex. This could, in turn, slow down launching as well as widespread adoption of various innovative solutions in the US forensic genomics market.

Opportunities

Adopting NGS is likely to witness the highest rate of growth, thereby facilitating more comprehensive and deeper analysis of the genetic information from the crime scenes. Integrating ML and AI could improve pattern recognition and automate the interpretation of data, particularly for complex DNA mixtures. Plus, developing and adopting secure, scalable, and accessible cloud-based platforms for data analysis and storage that offer potential for growth. Outsourcing the forensic genomics services, such as laboratory testing, training, and consulting, has immense scope, as the entities do seek expertise.

Category Wise Insights

By Product

• Analyzers & Sequencers

Analyzers & sequencers facilitate detailed analysis of physical traits, genetic variations, and ancestry, which, in turn, aids in the identification of individuals, solving cold cases, bettering disaster victim identification, and building the comprehensive DNA databases. Advanced sequencers are capable of analyzing samples that contain DNA from more than one source or are severely degraded. Conventional methods such as capillary Electrophoresis (CE) do struggle over here. The manufacturers are also introducing new software platforms and analyzers to integrate data analysis and sequencing, thereby streamlining the forensic workflow and cutting down on turnaround times.

• Software

The software segment is expected to witness a stellar CAGR in the US forensic genomics market during the forecast period. This could be due to the pressing need for precise as well as reliable forensic analysis. Integration of ML and AI in forensic software does revolutionize case investigations by provision of pattern recognition and predictive analysis. Also, regulatory requirements coupled with the push for standardized processes in forensic labs have resulted in growing adoption of software solutions to ascertain quality control and compliance.

• Kits & Consumables

The kits & consumables segment accounts for more than 60% of the market share. This could be credited to continual demand for DNA extraction kits, high-quality reagents, and sequencing consumables necessary for forensic genomic analysis. For example, in February 2020, Verogen launched a comprehensive NGS workflow designed for degraded forensic DNA samples. This move does integrate the Dental Forensic Extraction Kit (DFK), MiSeq FGx Forensic Genomics System, and InnoQuant HY DNA Quantification Kit, thereby collectively improving analysis and recovery of nuclear DNA from difficult samples such as teeth and bone.

By Method

• Capillary Electrophoresis

Capillary electrophoresis’ (CE’s) capacity of separating DNA fragments with higher resolution does assure reliable and precise results. This is critical in order to generate legally admissible DNA evidence in various criminal investigations. Advanced CE systems having multiple capillaries are capable of performing parallel analyses, thereby noticeably increasing throughput and speed of DNA analysis. This, in turn, allows the forensic laboratories to process a huge number of samples in an efficient manner, thereby addressing higher demand for DNA testing.

• Next-generation Sequencing (NGS)

NGS does generate high-resolution, extensive genetic information from the crime scene samples, thereby surpassing the capabilities of conventional methods. Technology does excel in the analysis of challenging samples that include highly mixed or degraded DNA, which is a common thing in forensic investigations. The ability to simultaneously analyzing a broad spectrum of markers inclusive of mitochondrial DNA (mtDNA) and single nucleotide polymorphisms (SNPs) does increase DNA analysis’ discriminatory power in an efficient assay.

• PCR Amplification

The core function of PCR is to effectively amplify fragmented DNA from the samples that are exposed to environmental factors. This technique allows direct amplification from the touch evidence, thereby curtailing potential loss of DNA and lessening the contamination pertaining to traditional extraction processes. PCR generates exclusive genetic profiles from STRs, which are important to match biological evidence. It also enables quicker analysis of genetic evidence, thereby enabling more efficient investigations.

By Application

• Criminal Testing

Rise in integration of DNA evidence in the criminal investigations for crimes such as sexual assaults and homicides does create a continuous demand for advanced forensic genomics tools and services. Forensic genomics, particularly with investigative genetic genealogy (IGG), is important to re-analyze cold cases and identify missing persons, thereby resulting in increasing adoption of such technologies by the law enforcement agencies.

• Paternity & Familial Testing

Paternity & familial testing helps in expediting personal and legal issues such as inheritance claims, immigration cases, child custody battles, and family reunification efforts. As such, the demand for reliable verification of biological relationships is on a continual rise. Also, enhancements in DNA analysis techniques such as developing more precise, sensitive, and automated DNA sequencing, end up making tests more affordable and reliable, thereby increasing their usage.

How are New Offerings Influencing the US Forensic Genomics Market?

In September 2024, QIAGEN N.V. entered into partnership with Bode technology to release the GEDmatch PRO genealogy database, which is used for helping forensic teams and police with genetic data’s investigative comparisons. A strong usage of consumables and reagents in numerous lab-based procedures to detect several samples of criminal cases has enabled their dominance in the product segment.

Report Scope

Key Developments

The US forensic genomics market is witnessing a significant organic and inorganic expansion. Some of the key developments include –

• In May 2025, QIAGEN announced that it had completed the acquisition of Genoox to enhance the former’s Digital Insights portfolio by integration of the latter’s Franklin platform. This cloud-based solution extends support to clinical decision-making through AI-driven, real-time NGS data analysis.

• In September 2024, Promega Corporation launched a new DNA polymerase designed for reducing stutter artifacts in the forensic DNA analysis on a significant note. Errors thus get minimized by amplification of short tandem repeats (STRs).

• In May 2024, QIAGEN announced that it had entered into a Cooperative Research and Development Agreement (CRADA) with the US FDI for developing a new digital PCR assay for the QIAcuity platform.

Leading Players

The US forensic genomics market is highly competitive, with a large number of service providers globally. Some of the key players in the market include:

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies
• Promega Corporation
• QIAGEN
• Bio-Rad Laboratories
• LGC Limited
• Tri Tech Forensics
• Verogen
• Others

These firms apply a plethora of strategies to enter the market, including innovations, mergers and acquisitions, and collaboration. The US forensic genomics market is shaped by the presence of diversified players that compete based on product innovation, vertical integration, and cost efficiency.

The US Forensic Genomics Market is segmented as follows:

By Product

• Analyzers & Sequencers
• Software
• Kits & Consumables

By Method

• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification

By Application

• Criminal Testing
• Paternity & Familial Testing

[embedsocial_reviews id=”d4ae80cffae3d938f997111953699a733c8e6f99″]